ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in ...

They found that a natural compound called phytoene, found in many fruits and vegetables, can extend the lifespan of a tiny ...

Royal Melbourne Hospital (RMH) is one of more than a dozen sites around Australia taking part in the major global trial for ...

New research published in Molecular Neurodegeneration has revealed that mutations in three genes known to cause familial ...

The father of the dominant theory of Alzheimer’s disease told another eminent researcher he is “causing harm” by criticizing his theory ...

This groundbreaking research reveals that subtle chemical changes in tau may quietly set off a chain reaction, spreading dysfunction across the brain. By identifying these early events, researchers ...

Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help ...

Researchers are uncovering new evidence showing infection may play a significant role in the development of Alzheimer’s ...

Panelists discuss how the current Alzheimer disease treatment landscape represents both significant progress with novel amyloid-targeting therapies and ongoing challenges, while expressing hope for ...

Scientists know that Alzheimer’s is linked to the buildup of harmful substances in the brain called beta-amyloid plaques and ...

Amyloid plaques have long been the suspected cause of cognitive decline experienced by Alzheimer's patients. For two decades ...

People react in various ways when they learn about their risk for Alzheimer’s, underscoring the importance of how such news is delivered.